Johnson & Johnson Price to Book Ratio 2010-2024 | JNJ

Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of November 04, 2024 is 5.50.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Johnson & Johnson Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-11-01 160.13 5.49
2024-09-30 162.06 $29.14 5.56
2024-06-30 145.06 $29.72 4.88
2024-03-31 155.72 $29.09 5.35
2023-12-31 153.13 $28.57 5.36
2023-09-30 150.96 $29.59 5.10
2023-06-30 159.29 $29.41 5.42
2023-03-31 148.04 $27.27 5.43
2022-12-31 167.54 $29.39 5.70
2022-09-30 153.95 $28.51 5.40
2022-06-30 166.16 $29.04 5.72
2022-03-31 164.86 $28.41 5.80
2021-12-31 158.11 $28.16 5.62
2021-09-30 148.28 $26.69 5.55
2021-06-30 150.36 $26.44 5.69
2021-03-31 149.07 $25.01 5.96
2020-12-31 141.87 $24.04 5.90
2020-09-30 133.27 $24.49 5.44
2020-06-30 125.05 $23.92 5.23
2020-03-31 115.80 $23.28 4.97
2019-12-31 127.98 $22.59 5.67
2019-09-30 112.73 $22.13 5.10
2019-06-30 121.36 $23.01 5.27
2019-03-31 120.97 $22.20 5.45
2018-12-31 110.95 $22.44 4.94
2018-09-30 118.03 $24.09 4.90
2018-06-30 102.97 $23.45 4.39
2018-03-31 107.95 $23.58 4.58
2017-12-31 116.95 $22.43 5.21
2017-09-30 108.17 $27.55 3.93
2017-06-30 109.37 $26.78 4.08
2017-03-31 102.29 $26.10 3.92
2016-12-31 94.01 $26.02 3.61
2016-09-30 95.73 $26.73 3.58
2016-06-30 97.65 $26.47 3.69
2016-03-31 86.49 $26.40 3.28
2015-12-31 81.52 $25.82 3.16
2015-09-30 73.54 $25.86 2.84
2015-06-30 76.18 $25.69 2.97
2015-03-31 78.07 $24.45 3.19
2014-12-31 80.59 $25.06 3.22
2014-09-30 81.61 $27.31 2.99
2014-06-30 79.56 $27.65 2.88
2014-03-31 74.19 $27.08 2.74
2013-12-31 68.68 $26.25 2.62
2013-09-30 64.56 $24.75 2.61
2013-06-30 63.47 $24.75 2.56
2013-03-31 59.81 $23.85 2.51
2012-12-31 51.02 $23.33 2.19
2012-09-30 49.72 $23.08 2.15
2012-06-30 48.31 $21.97 2.20
2012-03-31 46.71 $22.35 2.09
2011-12-31 46.04 $20.95 2.20
2011-09-30 44.30 $22.52 1.97
2011-06-30 45.86 $22.67 2.02
2011-03-31 40.49 $21.86 1.85
2010-12-31 41.89 $20.66 2.03
2010-09-30 41.61 $20.85 2.00
2010-06-30 39.29 $19.19 2.05
2010-03-31 42.98 $19.19 2.24
2009-12-31 42.14 $18.37 2.29
2009-09-30 39.52 $18.27 2.16
2009-06-30 36.58 $16.79 2.18
2009-03-31 33.57 $15.87 2.12
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $385.533B $85.159B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $777.423B 80.52
Novo Nordisk (NVO) Denmark $502.334B 38.34
AbbVie (ABBV) United States $359.539B 18.93
Merck (MRK) United States $258.042B 17.12
Novartis AG (NVS) Switzerland $223.511B 14.86
AstraZeneca (AZN) United Kingdom $221.444B 19.73
Pfizer (PFE) United States $159.177B 10.89
Sanofi (SNY) $135.190B 12.25
Innoviva (INVA) United States $1.205B 6.69